Microsoft word - oxford endocrinology masterclass programme year 2.doc

OXFORD ENDOCRINOLOGY MASTERCLASS
OXFORD CENTRE FOR DIABETES, ENDOCRINOLOGY
AND METABOLISM
DISORDERS OF GROWTH AND DEVELOPMENT, THYROID
GLAND, APPETITE AND WEIGHT, METABOLISM
12TH-13TH SEPTEMBER 2013
ST CATHERINE’S COLLEGE, OXFORD
PROGRAMME
THURSDAY 12TH SEPTEMBER 2013
9.15-9.45
Registration and Coffee
9.45-10.00
WELCOME AND MEETING OBJECTIVES
10.00-10.30
METHODS OF ASSESSMENT OF NORMAL GROWTH – GROWTH CHARTS
Dr. Lynn Ahmed, Clinical Auxologist
Oxford Children’s Hospital, Oxford University Hospitals NHS Trust
10.30-11.15
HYPOPITUITARISM IN CHILDHOOD: DIAGNOSIS AND MANAGEMENT
Dr. Fiona Ryan, Consultant in Paediatric Endocrinology and Diabetes
Oxford Children’s Hospital, Oxford University Hospitals NHS Trust
11.15-11.30
Coffee break
11.30-12.00
OBESITY: MEDICAL MANAGEMENT
Prof. Nick Finer, Consultant Endocrinologist and Bariatric Physician
UCLH Centre for Weight Loss, Metabolic and Endocrine Surgery
University College London Hospitals
12.00-12.30
TRANSITION OF THE PAEDIATRIC ENDOCRINE PATIENT: WHAT THE
ADULT ENDOCRINOLOGIST NEEDS TO KNOW

Dr. Helena Gleeson, Consultant Endocrinologist
Department of Diabetes and Endocrinology
Leicester Royal Infirmary
12.30-14.00
Lunch break
14.00-14.30
THYROID FUNCTION TESTS: ASSAYS, PITFALLS
Dr. Mark Gurnell, University Lecturer & Honorary Consultant Physician
Metabolic Research Laboratories, University of Cambridge
14.30-15.00
IMAGING OF THE THYROID: WHAT THE ENDOCRINOLOGIST NEEDS TO
KNOW

Dr. Kevin Bradley, Consultant Radiologist
Radiology Department, Oxford University Hospitals NHS Trust
15.00-15.30
Coffee break
15.30-16.00
HYPOTHYROIDISM:
LEVOTHYROXINE,
TRIIODOTHYRONINE
ARMOUR THYROID?
Prof. Colin Dayan, Professor of Clinical Diabetes and Metabolism
Institute of Molecular and Experimental Medicine
Cardiff University School of Medicine
16.00-16.30
SUBCLINICAL THYROID DISEASE
Dr. Mark Vanderpump, Consultant Physician & Honorary Senior
Lecturer in Diabetes and Endocrinology

Royal Free London NHS Foundation Trust
16.30-17.15
PLENARY LECTURE: THYROID EYE DISEASE
Prof. Wilmar Wiersinga, Emeritus Professor of Endocrinology
University of Amsterdam, The Netherlands
17.15-17.20
19.00-21.00
FRIDAY 13TH SEPTEMBER 2013
9.30-10.00
AMIODARONE-INDUCED THYROID DISEASE
Prof. Wilmar Wiersinga, Emeritus Professor of Endocrinology
University of Amsterdam, The Netherlands
10.00-10.30
THYROID NODULES: MANAGEMENT AND INTERPRETATION OF FNA
RESULTS

Mr. Radu Mihai, Consultant Endocrine Surgeon
Department of Surgery, Oxford University Hospitals NHS Trust
10.30-11.00
THYROID FUNCTION AND DISORDERS DURING PREGNANCY
Dr. Oier Ateka, Locum Consultant Obstetric Physician
Women’s Centre, Oxford University Hospitals NHS Trust
11.00-11.30
Coffee break
11.30-12.00
CHALLENGING CASES OF MEDULLARY THYROID CANCER
Prof. Gregory Kaltsas, Consultant Endocrinologist
Medical School, National University of Athens, Greece
12.00-12.45
CHALLENGING CASES OF FOLLICULAR THYROID CANCER
Dr. Kate Newbold, Consultant Clinical Oncologist,
The Royal Marsden NHS Foundation Trust
12.45-14.00
14.00-14.30
RADIOACTIVE IODINE FOR BENIGN THYROID DISEASE
Dr. Niki Karavitaki, Consultant Endocrinologist & Honorary Senior
Lecturer in Endocrinology

Oxford Centre for Diabetes, Endocrinology and Metabolism
University of Oxford & Oxford University Hospitals NHS Trust
14.30-15.00
HYPONATRAEMIA: INVESTIGATION AND MANAGEMENT
Prof. Ashley Grossman, Professor of Endocrinology
Oxford Centre for Diabetes, Endocrinology and Metabolism
University of Oxford & Oxford University Hospitals NHS Trust
15.00-15.30
Coffee break
15.30-16.00
HYPOKALAEMIA: INVESTIGATION AND MANAGEMENT
Prof. Ashley Grossman, Professor of Endocrinology
Oxford Centre for Diabetes, Endocrinology and Metabolism
University of Oxford & Oxford University Hospitals NHS Trust
16.00-16.30
OBESITY: SURGICAL MANAGEMENT
Mr. Bruno Sgromo, Consultant Bariatric Surgeon
Department of Surgery, Oxford University Hospitals NHS Trust

Source: http://www.ocdem.ox.ac.uk/_asset/file/oxford-endocrinology-masterclass-2013.pdf

Adler acryl-color 40420 in poi

Pullex Imprägnier-Grund 50258 in poi Impregnante Pullex Descrizione del prodotto Impregnante al solvente, privo di composti aromatici, per il Fai-da-te e il pittore professionista, contiene agenti biocidi, per proteggere elementi di legno all’esterno. Caratteristiche particolari Le sostanze attive utilizzate permettono di raggiungere la prot

Rmoc

INTERNATIONAL JOURNAL OF BUSINESS, 17(4), 2012 ISSN: 1083-4346 Risk management and Organizational Communication: Two Cases in the Pharmaceutical Industry Associate Professor, Faculté d'Economie Appliquée CERGAM, Université Paul Cézanne Aix-Marseille III., France [email protected] ABSTRACT In this article, we propose an organizational communication oriented

Copyright © 2010 Health Drug Pdf